Form 4: Cardio Diagnostics Director Paul Burton Reports Stock Option Transaction
SEC Form 4 Filing
Director Paul Frederick Burton reports acquisition and disposal of stock options in Cardio Diagnostics Holdings, Inc.
Summary
- On December 31, 2024, Director Paul Frederick Burton engaged in a transaction involving stock options of Cardio Diagnostics Holdings, Inc.
- Burton acquired 4,544 stock options with an exercise price of $0.92.
- The acquired options are exercisable starting December 31, 2024, and expire on December 31, 2034.
- Burton disposed of 30,805 stock options with an exercise price of $0.92.
- Following the reported transactions, Burton owns 4,544 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock option transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings and transactions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the director's stake in the company.
- The transaction may have a minor impact on the stock price depending on market perception.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of earliest transaction: Acquisition of 4,544 stock options and disposal of 30,805 stock options. |
| 12/31/2024 | Date stock options are exercisable. |
| 12/31/2034 | Expiration date of the stock options. |
| 01/15/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.